Peyronie's disease is an abnormal curvature of the penis that affects sexual intercourse. The treatment options include injection therapy into the scar or surgical correction of the curvature using plication or grafting.

Peyronie's disease is not a rare disorder, and it can be devastating to the affected man. Although the gold-standard treatment of Peyronie's disease is surgery in the stable phase, nonoperative management is preferred by some men and is the only treatment option in the acute phase of the disease, when surgery is contraindicated.

This study aimed to assess the safety, efficacy, and patient satisfaction of superficial radiation therapy in the treatment of Peyronie's disease (PD) in a retrospective analysis.We performed a retrospective analysis of 83 patients who underwent radiation therapy between 1999 and 2008 with 8 fractions of 4 Gy over a period of 6 months.

What Is beyond 9%

Whether you’ve just been diagnosed with Peyronie’s disease or have known for some time, it can be difficult to see beyond the frustrations and limitations that regularly confront you. But rest assured, you’re not alone. In fact, more than 9% of men may develop Peyronie’s. At the APDA, we understand the challenges you’re facing. We’re patients, partners and physicians dealing with it each and every day. And we’re dedicated to helping you go beyond Peyronie’s and back to a more fulfilling life. Learn more

Welcome to APDA

Because the founder of the APDA has Peyronie’s disease, he understands what it’s like. Hear from him and members of the Medical Advisory Board about the organization and its mission to help patients become their own advocates.

If you could help other men with Peyronie’s disease get the help they deserve, would you?

Register for our newsletter!

To help you find answers and better understand this condition, a question-and-answer forum has been developed, where Dr. Laurence Levine and Dr. John Mulhall, along with other members of the APDA Medical Advisory Board and guest contributors, answer questions from patients and their partners. As leaders in Peyronie’s disease research and treatment, board members provide comprehensive and unbiased information about a broad range of topics.